NCT02601378 A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma. Status TERMINATED Phase PHASE1
NCT02598297 Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations. Status TERMINATED Phase PHASE3
NCT02596009 Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices Status COMPLETED Phase PHASE4
NCT02595970 Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE3
NCT02584933 Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT02580708 Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02577926 The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02576639 Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age Status COMPLETED Phase PHASE2
NCT02573467 An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 Status COMPLETED Phase PHASE3
NCT02571777 Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma Status COMPLETED Phase PHASE3
NCT02570854 A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients Status COMPLETED Phase PHASE1
NCT02568943 An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma Status NO_LONGER_AVAILABLE Phase N/A
NCT02566044 Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT02566031 A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients Status COMPLETED Phase PHASE4
NCT02565576 Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis Status COMPLETED Phase PHASE2
NCT02565511 A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Status TERMINATED Phase PHASE2/PHASE3